Verastem takes AbbVie’s blood cancer castoff to the FDA
A blood cancer drug that’s passed through the hands of several companies – disappointing drugmakers along the way – is finally headed to the FDA …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
